12:00 AM
 | 
Nov 19, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: G protein-coupled receptor 183 (GPR183; EBI2)

Musculoskeletal disease

INDICATION: Osteoporosis

Mouse studies suggest inhibiting GPR183 could help treat osteoporosis. In male mice, knockout of GPR183 increased bone mass compared with...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >